Related Experiment Videos
Meningococcal meningitis
1Gloucestershire Royal Hospital.
Abstract:
Meningococci continue to cause outbreaks of disease throughout the world. The UK is currently experiencing an upsurge due to organisms of groups B and C. There is substantial under-reporting of meningococcal disease, only meningitis currently being notifiable. All significant meningococcal strains should be typed by a reference laboratory. New approaches to vaccine development permit cautious optimism for the future.
Insights
Meningococcal disease outbreaks, particularly from groups B and C, are occurring globally and in the UK. Advances in vaccine development offer hope for future prevention strategies against this significant public health threat.
Area of Science:
- Microbiology
- Epidemiology
- Public Health
Background:
- Meningococci bacteria are a persistent cause of global disease outbreaks.
- The United Kingdom is currently facing an increase in meningococcal disease cases, primarily caused by serogroups B and C.
- Under-reporting of meningococcal disease is a significant issue, with only meningitis being a notifiable condition.
Purpose of the Study:
- To highlight the ongoing threat of meningococcal disease outbreaks worldwide.
- To emphasize the current epidemiological situation in the UK regarding meningococcal serogroups B and C.
- To advocate for comprehensive strain typing and discuss future vaccine development.
Main Methods:
- Review of current epidemiological data on meningococcal disease.
- Analysis of reporting practices for meningococcal infections.
- Assessment of advancements in vaccine technology.
Main Results:
- Meningococcal outbreaks remain a global concern.
- Serogroups B and C are driving current UK outbreaks.
- Under-reporting necessitates improved surveillance and typing.
Conclusions:
- Effective control of meningococcal disease requires robust surveillance and reference laboratory typing of significant strains.
- Ongoing research and new vaccine development approaches provide a hopeful outlook for mitigating future outbreaks.